Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents
US12139535B2 · kind B2 · utility
0Cited by
6References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2021 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Apr 18, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.